• Chandra Kangga moehammad hoesin general hospital Palembang
  • Denny Satria Utama Department of Otorhinolaryngology Head and Neck Surgery Faculty ofMedicine Universitas Sriwijaya, RSUP Dr. Moehammad Hoesin Palembang




Nasopharyngeal carcinoma, survival rate, prognostic factors


Introduction: The survival rate of Nasopharyngeal carcinoma (NPC) patients is influenced by several prognostic factors, Such aspatient factors, tumor factors and therapeutic interventions carried out as well as the quality of care. Tumor factors in the form of spread of local invasion, regional lymphatic involvementand metastasis that is reflected in the TNM stage (Tumor, Nodule and Metastatic) are the most important prognostic factors of NPC.

Objective: To determine the Prognostic factors that effectedsurvival rate of nasopharyngeal carcinoma patients.

Material and methods: Analytic observational studywith particular design of survival analysis. Data was taken from medical records and then performed survival analysis on the studiedfactors. Sample of this studywas all patients who were first diagnosed NPC From January 2013 until December 2013 and meetinclusion and exclusion criteria is52 patients.

Results:From 52 patients in the fifth year, 50% died and 50% survive. Survival was worse in the 30-39 year age group (30.8%), male sex (47.2%), Stage IV (44.4%), T4 size (40%), N1 size (23,1%), Distant metastases (40%), WHO type III (48.5%), chemoradiation (48.9%). In multivariate analysis, it was found that the variables that most influenced the survival of NPC patients based on p <0.05 and based on hazard ratio strength were T-size, N-size categories and Metastasis with 95% CI.

Conclusion: Prognostic factors that affect the survival of NPC patients in RSUP. Dr. Mohammad Hoesin Palembang is a category of size T, N, and Metastasis.


[1] Faiza S, Rahman S, Asri A. Karakteristik klinis dan patologis karsinoma nasofaring di bagian THT-KL RSUD Dr. M. Djamil Padang. Jurnal Kesehatan Andalas. 2016; 5 (1): 1-7.
[2] Melani W, Sofyan F. Karakteristik pasien kanker nasofaring di RS H. Adam Malik Medan tahun 2011. E-jurnal FK USU. 2013; 1(1): 1-5.
[3] Komite Penanggulangan Kanker Nasional. Pedoman Nasional Pelayanan Kedokteran Kanker Nasofaring. Kementerian Kesehatan Republik Indonesia. 2015; 1-99.
[4] Wei WI, Chua DTT. Bailey’s Head and Neck Surgery Otorlaryngology Fifth Edition vol. 2. Lippincot Williams & Wilkins. China. 2014; 1875-93.
[5] Jack Z. Karsinoma Nasofaring. Buku Ajar Ilmu Penyakit Dalam Edisi VII. interna publishing. Jakarta. 2014; 2992-7.
[6] Adriana R. Kesintasan pasien karsinoma nasofaring dan faktor Yang mempengaruhinya di rumah sakit Hasan Sadikin. Program pendidikan dokter spesialis ilmu kesehatan THT-KL FK Universitas Padjajaran. Bandung. 2015; 33-37.
[7] American Cancer Society. Survival rates for nasopharyngeal cancer by Stage. 2011. Available from: https://www.cancer.org/cancer/nasopharyngeal-cancer/detection-diagnosis-staging/survival-rates.html.
[8] Zhou Q, He Y, Zhao Y, Wang Y, Kuang W, Shen Le. A Study of 358 cases of locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiation therapy: Improving the seventh edition of the AJCC on cancer T-Staging System. Biomed Research International. 2017; 1-11.
[9] Wu LR, Liu YT, Jian N, Fan YX, Wen J, et al. Ten-year survival outcomes for patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: An analysis of 614 patients from a single center. Oral Oncolgy. 2017; 69:26-32
[10] Rahman S, Budiman BJ, Subroto H. Faktor risiko non-viral pada karsinoma nasofaring. Jurnal kesehatan andalas. 2015; 4(3): 1-8.
[11] Liu M, Hsieh C, Chang T, Lin J, Huang C, Wang A. Prognostic Factors Affecting the Outcome of Nasopharyngeal Carcinoma. Jpn J Clin Oncol; 2003: 33(10)501-508. 

[12] Putri EB. Karakteristik Pasien Karsinoma Nasofaring Di Departemen Ilmu Kesehatan THT-KL FKUP/RSUP. DR. Hasan Sadikin Bandung Periode Tahun 2006-2010. Skripsi. Universitas Padjadjaran Fakultas Kedokteran, Bandung. 2011.
[13] Xiao G, Cao Y, Qiu X, Wang W, Wang Y. Influence of gender and age on the survival of patients with nasopharyngeal carcinoma. BMC Cancer; 2013: 13:226.
[14] Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiardjo dkk. Nasopharyngeal carcinoma in Indonesia : epidemiology, incidence, sign, and symptoms at presentation. Chin Journal of Cancer; 2012: 31(4):185-96.
[15] El-Sherbieny E, Rashwan H, Lubis SH, Choi VJ. Prognostic Factors in Patients with Nasopharyngeal Carcinoma Treated in Hospital Kuala Lumpur. Asian Pacific Journal of Cancer Prevention, 2011; 12:1739-43.
[16] Kataria T, Gupta D, Bisht SS, Goyal S, Basu T, Srivastava A, et al. Chemoradiation in elderly patients with head and neck cancers: a single institution experience. American journal of otolaryngology-head and neck medicine surgery. 2015; 117-121.
[17] Shen GP, Xu FH, He F, Ruan HL, Cui C, Chen LZ. Pretreatment lifestyle behaviour as survival predictors for patients with nasopharyngeal carcinoma. plos one. 2012; 7 (5): 1-8.
[18] Yarney S, Aryeetey NA, Mensah A, Kitcher ED, Vanderpuye V, Aidoo C, et al. Does concurrent chemoradiotherapy proceeded by chemotherapy improve survival in locally advanced nasopharyngeal cancer patients? experience from Ghana. Cancers of the head and neck. 2017; 2 (4): 1-7.
[19] Xiao G, Cao Y, Qiu X, Wang W, Wang Y. Influence of gender and age on the survival of patients with nasopharyngeal carcinoma. Bmc cancer. 2013;13(1):1.
[20] Yi J, Gao L, Huang X, Li S, Luo J, Cai W, et al. Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution. Int j radiat oncol biol phys. 2006;65(1):161-168.



How to Cite

Kangga C, Utama DS. FACTORS THAT HAVE PROGNOSTIC VALUES IN THE MANAGEMENT OF NASOPHARYNGEAL CARCINOMA PATIENTS. IJNPC [Internet]. 2020Mar.18 [cited 2020May27];2(01):21-4. Available from: https://talenta.usu.ac.id/IJNPC/article/view/3454